Mij
Senior Member (Voting Rights)
Abstract
To determine if using nicotine exacerbates exertional heat strain through an increased metabolic heat production (Hprod) or decreased skin blood flow (SkBF), ten nicotine-naïve trained males (37±12 y; VO2peak: 66±10 ml·min-1·kg-1) completed four trials at 20°C and 30°C following overnight transdermal nicotine (7mg·24h-1) and placebo use in a crossover, double-blind design.
They cycled for 60 min (55% VO2peak) followed by a time-trial (~75% VO2peak) during which measures of gastro-intestinal (Tgi) and mean weighted skin ( sk) temperatures, SkBF, Hprod, and mean arterial pressure (MAP) were made.
The difference in ∆Tgi between nicotine and placebo trials was greater during 30°C (0.4±0.5°C) than 20°C (0.1±0.7°C), with sk higher during nicotine than placebo trials (0.5±0.5°C, p=0.02). SkBF became progressively lower during nicotine than placebo trials (p=0.01) and progressively higher during 30°C than 20°C trials (p<0.01); MAP increased from baseline (p<0.01) and remained elevated in all trials. The difference in Hprod between 30°C and 20°C trials was lower during nicotine than placebo (p=0.01) and became progressively higher during 30°C than 20°C trials with exercise duration (p=0.03). Mean power output during the time-trial was lower during 30°C than 20°C trials (24±25 W, p=0.02), and although no effect of nicotine was observed (p>0.59) two participants (20%) were unable to complete their 30°C nicotine trials as one reached the ethical limit for Tgi (40.0°C) whilst the other withdrew due to "nausea and chills" (Tgi=39.7°C).
These results demonstrate that nicotine use increases thermal strain and risk of exertional heat exhaustion by reducing SkBF.
LINK
To determine if using nicotine exacerbates exertional heat strain through an increased metabolic heat production (Hprod) or decreased skin blood flow (SkBF), ten nicotine-naïve trained males (37±12 y; VO2peak: 66±10 ml·min-1·kg-1) completed four trials at 20°C and 30°C following overnight transdermal nicotine (7mg·24h-1) and placebo use in a crossover, double-blind design.
They cycled for 60 min (55% VO2peak) followed by a time-trial (~75% VO2peak) during which measures of gastro-intestinal (Tgi) and mean weighted skin ( sk) temperatures, SkBF, Hprod, and mean arterial pressure (MAP) were made.
The difference in ∆Tgi between nicotine and placebo trials was greater during 30°C (0.4±0.5°C) than 20°C (0.1±0.7°C), with sk higher during nicotine than placebo trials (0.5±0.5°C, p=0.02). SkBF became progressively lower during nicotine than placebo trials (p=0.01) and progressively higher during 30°C than 20°C trials (p<0.01); MAP increased from baseline (p<0.01) and remained elevated in all trials. The difference in Hprod between 30°C and 20°C trials was lower during nicotine than placebo (p=0.01) and became progressively higher during 30°C than 20°C trials with exercise duration (p=0.03). Mean power output during the time-trial was lower during 30°C than 20°C trials (24±25 W, p=0.02), and although no effect of nicotine was observed (p>0.59) two participants (20%) were unable to complete their 30°C nicotine trials as one reached the ethical limit for Tgi (40.0°C) whilst the other withdrew due to "nausea and chills" (Tgi=39.7°C).
These results demonstrate that nicotine use increases thermal strain and risk of exertional heat exhaustion by reducing SkBF.
LINK